A nonprofit health advocacy group wants Bayer to swallow yet another bitter legal pill over its marketing techniques -- this one involving its Men's One A Day multivitamin. The Center for Science in the Public Interest is suing the German drug giant for allegedly claiming falsely that selenium in the multivitamin might reduce the risk of prostate cancer. The lawsuit comes on the heels of several multimillion-dollar settlements that Bayer has paid out to resolve claims about misleading ads for other products.
October 07, 2009 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A nonprofit health advocacy group wants Bayer to swallow yet another bitter legal pill over its marketing techniques — this one involving its Men’s One A Day multivitamin.
The Washington, D.C.-based Center for Science in the Public Interest (CSPI) is suing the German drug giant for allegedly claiming falsely that selenium in the men’s multivitamin might reduce the risk of prostate cancer.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
